Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
APM | US
-0.03
-1.78%
Healthcare
Biotechnology
31/03/2024
17/10/2024
1.66
1.66
1.70
1.65
Aptorum Group Limited a biopharmaceutical company engages in the discovery development and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD a pathogen molecular diagnostic; NativusWell DOI (NLS-2) a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3 an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets such as systematic screening of existing approved drug molecules and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology gastroenterology metabolic disorders women's health and other disease areas. In addition it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
66.4%1 month
98.6%3 months
80.3%6 months
94.4%-
-
0.38
0.14
0.16
-0.45
24.90
-
-9.60M
9.08M
9.08M
-
-2.49K
-
-100.00
-37.40
0.11
0.08
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.38
Range1M
1.33
Range3M
2.21
Rel. volume
0.52
Price X volume
20.41K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
SNTI | SNTI | Biotechnology | 2.15 | 9.84M | -1.83% | n/a | 80.96% |
KPRX | KPRX | Biotechnology | 3.31 | 9.83M | -2.65% | 0.21 | 0.25% |
BioCardia Inc | BCDA | Biotechnology | 2.65 | 9.46M | 0.57% | n/a | -58.03% |
Soligenix Inc | SNGX | Biotechnology | 3.63 | 8.47M | 2.83% | n/a | 84.28% |
Arsanis Inc | ASNS | Biotechnology | 1.4 | 8.43M | 1.45% | n/a | 252.35% |
Galecto Inc | GLTO | Biotechnology | 6.73 | 8.40M | 0.30% | n/a | 0.33% |
Plus Therapeutics Inc | PSTV | Biotechnology | 1.41 | 8.31M | -1.40% | n/a | -45.04% |
Mustang Bio Inc | MBIO | Biotechnology | 0.2171 | 8.08M | -1.23% | n/a | -13.03% |
Pulmatrix Inc | PULM | Biotechnology | 2.03 | 7.41M | -4.70% | n/a | 0.18% |
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.64 | 7.34M | -1.20% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a | |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.54 | 0 | -1.56% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.45 | 0.53 | Cheaper |
Ent. to Revenue | 24.90 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.38 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 80.31 | 72.92 | Par |
Debt to Equity | 0.14 | -1.24 | Expensive |
Debt to Assets | 0.16 | 0.25 | Cheaper |
Market Cap | 9.08M | 3.78B | Emerging |